City page
Photo: Milestoned from Deutschland (Germany) · CC BY 2.0Mainz biotech and pharma directory
Mainz has a concentrated set of organisations working across mRNA, cancer immunology, diagnostics, and translational research. BioNTech reports its headquarters in Mainz, including laboratory, GMP manufacturing, storage, and office space. TRON is an independent non-profit translational research institute founded in Mainz, working at the boundary of academic research and pharmaceutical development. The University Medical Center Mainz adds a clinical and academic research base. Use the individual profiles to confirm which programme, address, and quality evidence apply to a potential partner.
Where does this city read strongest?
Diagnostics (2) and Therapeutics (1). Most visible records: ORGENTEC Diagnostika, Mainz Biomed, and BioNTech SE.
Which standards and public evidence are already visible?
GMP (1), GLP (1), and ISO-13485 (1). Latest review: 22 March 2026. Review cycle: March 2026.
Why does this city matter?
This page brings visible companies and infrastructure records into one practical view of Mainz.
Local sources
Primary sources for the local ecosystem
These links let you verify this page’s local context with the primary institution.
BioNTech annual filing
BioNTech’s filing describes its Mainz headquarters and the laboratory, GMP manufacturing, storage, and office space it occupies there.
Open sourceTRON Translational Oncology
TRON’s account of its independent non-profit translational-research role and its Mainz academic and public partners.
Open sourceUniversity Medical Center Mainz research
The medical center’s overview of its research support, research profile, and collaborations.
Open sourceBy category
Mainz by category
Jump into a category page filtered to this country only.
Full list
Mainz biotech and pharma directory
3 city records currently match the active filter.
Current review cycle
ORGENTEC Diagnostika
MainzGermanyDiagnostics
Mainz diagnostics company focused on autoimmune and infectious-disease testing, with broad immunology assay operations from a German IVD platform.
- Lead
- Gregoire AllazChief Executive Officer
- Scale
- Diagnostics platform
Current review cycle
Mainz Biomed
MainzGermanyDiagnostics
Mainz diagnostics company developing molecular screening tests for colorectal and pancreatic cancer from a German diagnostics base.
- Lead
- Guido BaechlerChief Executive Officer
- Scale
- Diagnostics platform
Current review cycle
BioNTech SE
MainzGermanyTherapeutics
Mainz mRNA and immunotherapy headquarters coordinating BioNTech's oncology pipeline, manufacturing network, and clinical execution ahead of the planned 2026 launch window.
- Lead
- Ugur SahinCEO and Co-Founder
- Scale
- Commercial Phase
FAQ
Frequently asked questions
- What is BioNTech and where is it based?
- BioNTech is a biotechnology company headquartered in Mainz. Its public filing describes laboratory, GMP manufacturing, storage, and office space at its headquarters. Its current programmes and operational footprint can change, so use BioNTech’s own materials and the cited profile evidence for a current assessment.
- What is TRON?
- TRON gGmbH is an independent non-profit translational-research institute in Mainz. It was founded in 2010 to bridge academic science and market-oriented pharmaceutical development, with the State of Rhineland-Palatinate, Johannes Gutenberg University Mainz, and the University Medical Center Mainz among its stakeholders.
- What sectors are strongest in Mainz biotech?
- The current Mainz records span mRNA-related biotechnology, cancer immunology, translational research, diagnostics, and associated clinical research. Review the individual company or institution profile for its actual modality, development stage, address, and quality evidence rather than inferring them from the city page.
Related briefs
Briefs that mention Mainz
European mRNA & Immunotherapy Supply Chain 2026
Where the European mRNA, vaccine, and immunotherapy supply chain actually sits in 2026 - BioNTech, CureVac, IDT Biologika, AGC Biologics, BioSpring, Bachem, plus the Nordic vaccine layer - and how the pieces fit.
Open briefGerman Biotech & Pharma Landscape 2026: Heidelberg, Berlin, Mainz
A practical map of the German biotech and pharma landscape in 2026 - 57 operators across Heidelberg, Berlin, Mainz, Hamburg, Munich, and smaller sites, organised by what they actually do and how the pieces connect.
Open briefEuropean Vaccines Landscape 2026: Biodefence, mRNA, Allergen, Infectious Disease
A practical map of the European vaccines sector in 2026 - Bavarian Nordic MVA-BN biodefence, BioNTech and CureVac mRNA, ALK-Abelló allergen immunotherapy, Valneva infectious-disease vaccines, Statens Serum Institut, plus a specialised clinical-stage innovator layer.
Open briefNext step
Read the city, then widen the view.
Use country and regional pages for wider context, and the company suggestion form for new candidate records.